|









   
|
Treating the Symptoms
Therapeutic Reduction Amniocentesis
: This is the ‘most widely available therapy’
and involves draining the excess amniotic fluid (polyhydramnios)
by inserting a needle into the amniotic sac of the recipient.
It relieves the mother’s abdominal discomfort, and prolongs
TTTS pregnancies by reducing the risk of spontaneous rupture
of the membranes or premature labor from the enlarged uterus.
In addition, by reducing the pressure inside the womb, it
has been reported to change the nature of the transfusion
in some TTTS cases. Survival rates with amniocenteses approach
80% in some centers, but health status of surviving infants
are not always reported. Recent reports (see section of Medical
Research and Articles) indicate a 60-75% survival rate with
amniocentesis, but 10-30% of the survivors have had neurological
(brain) abnormalities when ultrasounds were performed in the
nursery. Since the babies remain connected, there is the continuing
transfusion process between the twins (both chronic and acute).
This may explain the higher rate of medical problems in the
surviving babies than methods that disconnect the babies.
Amniotic Septostomy:
This is the intentional creation of a hole in the membrane
septum between the babies’ bags of water with a needle
during ultrasound scanning. It allows for some of the excess
amniotic fluid in the recipient’s bag of water to enter
the sac of the donor who usually has no to very little amniotic
fluid. In one report of 12 TTTS cases, the septostomy to delivery
interval was 8.5 weeks and 83% (20/214) of the twins survived.
The health of the surviving twins was not given. The babies
remain connected with this, and there is now the additional
risks associated with twins who sit in the same sac (monoamnionic)
such as possible umbilical cord entanglement.
Medication Therapy:
Several drugs have been used in TTTS cases for various purposes.
These include:
· Digoxin Therapy for Fetal Heart Failure: Here doctors
give this heart medication as pills to the mother, or inject
it directly into the twin that is showing signs of heart failure.
Giving this medication may help the heart beat stronger when
it is overloaded with blood.
· Indomethacin Therapy to Curtail Amniotic Fluid Production:
Here doctors also give this mediation to the mother hoping
to decrease the urine output in the recipient and lessen the
amount of polyhydramious. Indomethacin is an aspirin-like
medication (non-steroidal anti-inflammatory drug) with numerous
side effects in the baby, one of which is on the kidney where
decreased urine production occurs. It is the most powerful
drug for treating pre-term labor and is used more often for
this purpose in TTTS. When used as a single treatment for
TTTS cases, the results have been disappointing.
· Tocolytic Medications to Stop Premature Labor: In
addition to indomethacin, there are several other drugs that
are used in TTTS cases to stop labor.
|
|
click for story
Sophie and
Sara
I underwent the laser surgery on August
14th, 2002, at only 18 1/2 weeks of pregnancy. In the operating
room, Dr. De Lia keeps prayer cards of Saints Gerard and Jude, the
patron Saints of pregnancy and hopeless causes. Just before the
surgery, we said a prayer together and asked St. Gerard to help
our babies stay strong. I drifted off under the anesthesia, knowing
that I was in the hands of a faith-filled surgeon who is totally
dedicated to saving little twin babies with TTTS.
On December 15th, 2002, over eighteen weeks
after their in-utero surgery, our beautiful little angels Sophie
and Sara were born
Katie , Mother of Sophie
of Sara |